RxDoctor Payments Data

Lindsay Little, NP

Family · Bay City, MINPI 1497278923

Payments from drug & device makers

$1,145in general payments, 2019–2025

Across 64 payments — averaging $17.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lundbeck LLC$171
  • AbbVie$158
  • Pfizer$94
  • Johnson & Johnson$92
  • Otsuka America Pharmaceutical, Inc.$78
  • Biohaven Pharmaceutical Holding Company Ltd.$58
  • plus $494 from 18 others

What the payments were for

  • Food & beverage$1,11798%
  • Education$282%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,145 in reported general payments places this provider in the 70th percentile of 3,657 family providers in Michigan.

See all family providers in Michigan

Medicare billing

Part B allowed, 2024
$1,053
Medicare patients
39
Services billed
166

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide169$181,263
TrulicityDulaglutide82$109,600
JardianceEmpagliflozin96$102,865
JanuviaSitagliptin Phosphate68$75,940
Breztri AerosphereBudesonide/Glycopyr/Formoterol99$73,976
FarxigaDapagliflozin Propanediol40$56,510
EliquisApixaban52$55,096
MounjaroTirzepatide50$53,672
Trelegy ElliptaFluticasone/Umeclidin/Vilanter36$37,874
VraylarCariprazine Hcl12$16,451
Incruse ElliptaUmeclidinium Bromide22$13,704
Lantus SolostarInsulin Glargine,hum.Rec.Anlog97$13,452
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog24$12,238
Spiriva HandihalerTiotropium Bromide11$12,133
SymbicortBudesonide/Formoterol Fumarate35$8,058

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$57$181,263169 claims
Lilly USA, LLCTrulicity, Mounjaro$32$163,272132 claims
AstraZenecaBreztri Aerosphere, Farxiga, Symbicort$12$138,544174 claims
Boehringer IngelheimJardiance$21$102,86596 claims
MerckJanuvia$44$75,94068 claims
PfizerEliquis$94$55,09652 claims
GSKTrelegy Ellipta, Incruse Ellipta, Shingrix$15$54,54973 claims
AbbVieVraylar$158$16,45112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,657 family providers in Michigan.

Other family in Bay City

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →